Literature DB >> 11979369

Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition.

Christer Busch1, Tor Arne Hanssen, Christoph Wagener, Björn OBrink.   

Abstract

Many cancers have altered expression of various cell adhesion molecules. One of these is CEACAM1, which has been found to be downregulated in several carcinomas, including prostate cancer. We explored its immunohistochemical expression in a set of 64 total prostatectomy specimens and compared it with that of the epithelial cell adhesion molecule E-cadherin and occludin, a tight junction-associated molecule. The luminal surface of the epithelial cells of normal prostate glands and ducts showed a dense expression of CEACAM1. This pattern prevailed in prostate cancer of Gleason grades 1 to 3 as long as the cells maintained their polarity and formed individual glands. With "fusion" of glands (ie, in the transition to Gleason grade 4), the expression of CEACAM1 was lost in polygonal nonpolar cells and was lost or focally very weak in cells lining a lumen in the cribriform complexes. E-cadherin, which outlined the basolateral cell membranes of contacting neighboring epithelial cells was also downregulated in prostate carcinomas. However, the loss of E-cadherin expression in higher grades was gradual and not related to the Gleason 3 to >4 transition. Occludin was also lost in polygonal (ie, unpolarized) cells of Gleason grades 4 and 5, but remained expressed in all cells facing a lumen in all grades of cancer, which CEACAM1 was not. In conclusion, downregulation of CEACAM1 as well as that of occludin in prostate cancer is associated with loss of cell polarity. It coincides with the formation of the complex glandular architecture of Gleason grade 4 pattern or complete loss thereof in Gleason grade 5 patterns. The proliferative activity, measured as Ki67 labeling index, showed a fourfold increase in the carcinoma cells with lost CEACAM1 expression, supporting previous observations that CEACAM1 regulates cell proliferation. Immunohistochemical analysis of CEACAM1 expression patterns may be useful in assessment of the malignant potential of prostate carcinoma. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979369     DOI: 10.1053/hupa.2002.32218

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  36 in total

Review 1.  Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment.

Authors:  Danila Coradini; Claudia Casarsa; Saro Oriana
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

2.  The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients.

Authors:  Gui-Xiang Liu; Qi Xie; Cheng-Jun Zhou; Xiao-Ying Zhang; Bo-Long Ma; Cheng-Qin Wang; Feng-Cai Wei; Xun Qu; Shan-Zhen Sun
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

3.  Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers.

Authors:  Jae Hwi Song; Zhang Cao; Jung Hwan Yoon; Suk Woo Nam; Su Young Kim; Jung Young Lee; Won Sang Park
Journal:  Pathol Oncol Res       Date:  2010-06-04       Impact factor: 3.201

Review 4.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell.

Authors:  Matthew J German; Azzedine Hammiche; Narasimhan Ragavan; Mark J Tobin; Leanne J Cooper; Shyam S Matanhelia; Andrew C Hindley; Caroline M Nicholson; Nigel J Fullwood; Hubert M Pollock; Francis L Martin
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

6.  CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.

Authors:  Shigehisa Kiriyama; Shozo Yokoyama; Masaki Ueno; Shinya Hayami; Junji Ieda; Naoyuki Yamamoto; Shunsuke Yamaguchi; Yasuyuki Mitani; Yasushi Nakamura; Masaji Tani; Lopa Mishra; John E Shively; Hiroki Yamaue
Journal:  Ann Surg Oncol       Date:  2014-01-06       Impact factor: 5.344

7.  Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Authors:  Kenneth J Dery; Craig Silver; Lu Yang; John E Shively
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

8.  Different expression of occludin and ZO-1 in primary and metastatic liver tumors.

Authors:  Erika Orbán; Erzsébet Szabó; Gábor Lotz; Péter Kupcsulik; Csilla Páska; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

9.  Regulation of CEACAM1 transcription in human breast epithelial cells.

Authors:  Marieta Gencheva; Charng-Jui Chen; Tung Nguyen; John E Shively
Journal:  BMC Mol Biol       Date:  2010-11-04       Impact factor: 2.946

10.  Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.

Authors:  Fei Su; Bruna R S Correa; Jianhua Luo; Ricardo Z N Vencio; Laura E Pascal; Zhou Wang
Journal:  Cancer Microenviron       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.